Other
Effective Income Tax Rate Reconciliation, FDII, Percent
Vertex Pharmaceuticals Effective Income Tax Rate Reconciliation, FDII, Percent decreased by 95.4% to 1.3% in Q4 2025 compared to the prior quarter. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementIncome Statement
SectionOther
CategoryProfitability
SignalHigher is better
VolatilityStable
First reportedQ4 2023
Last reportedQ4 2025Feb 13, 2026
How to read this metric
An increasing percentage indicates a greater reliance on or success in utilizing FDII tax benefits.
Detailed definition
This represents the percentage point impact of the Foreign-Derived Intangible Income (FDII) deduction on the company's e...
Peer comparison
Standard metric for U.S. companies with significant international operations.
Metric ID:
other_effective_income_tax_rate_reconciliation_fdii_percentHistorical Data
3 periods
| Q4 '23 | Q4 '24 | Q4 '25 | |
|---|---|---|---|
| Value | 1.7% | 28.3% | 1.3% |
| QoQ Change | — | >999% | -95.4% |
| YoY Change | — | >999% | -95.4% |
Range1.3% – 28.3%
Avg YoY Growth+734.6%
Median YoY Growth+734.6%
Effective Income Tax Rate Reconciliation, FDII, Percent at Other Companies
Frequently Asked Questions
- What is Vertex Pharmaceuticals's effective income tax rate reconciliation, fdii, percent?
- Vertex Pharmaceuticals (VRTX) reported effective income tax rate reconciliation, fdii, percent of 1.3% in Q4 2025.
- What does effective income tax rate reconciliation, fdii, percent mean?
- The percentage reduction in the effective tax rate due to the FDII tax incentive.